Respiratory Morbidity in Late Preterm and Early Term Born Infants

Respiratory morbidity in preterm infants in the neonatal period is associated with the development of not only respiratory complications and hospital admissions in childhood,¹ but also with the development of chronic respiratory disease in adulthood.²

Preventive strategies and collaboration with other healthcare professionals are essential to consider in view of the impact these morbidities have on patients and their families.

In this presentation, Anne Greenough, Professor of Neonatology and Clinical Respiratory Physiology, explores respiratory morbidity in late preterm and early term born infants and highlights how this can manifest in childhood, adolescence, and adulthood. She also makes reference to current research being undertaken in this area.

Please also consider watching the on-demand video “Late Preterm Morbidity: Non-Respiratory Outcomes” by Prof. Theodore Dassios.

References

1. Haataja P, Korhonen P, Ojala R, Mikko Hirvonen, Matti Korppi, Gissler M, et al. Hospital admissions for lower respiratory tract infections in children born moderately/late preterm. Pediatric Pulmonology. 2017 Nov 29;53(2):209–17.

2. Bui DS et al. Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study. Lancet Respir Med. 2022 May;10(5):478-484.

We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.

• Professor Anne Greenough

  Professor of Neonatology and Clinical Respiratory Physiology

  Read biography
  Professor Anne Greenough

  Professor of Neonatology and Clinical Respiratory Physiology King’s College London

  Role and Location
  Anne Greenough is Professor of Neonatology and Clinical Respiratory Physiology at King’s College London.

  Research
  Her research interests focus on the early origins of chronic respiratory disease and include factors affecting antenatal lung growth, optimisation of respiratory support, determinants of sudden infant death syndrome and prevention and treatment of chronic lung disease, particularly related to viral infections and sickle cell disease.

  Memberships
  Council for England and Chair of the National Institute for Health Research (NIHR) Paediatrics (non-medicines). She was Board Member of the Higher Education Funding Specialty Group and Vice President of Science and Research, Royal College of Paediatrics and Child Health (RCPCH) (2014-2019). Professor Greenough is a member of the Department of Women and Children’s Health, Faculty of Life Sciences and Medicine, King’s College London, and the Asthma UK Centre in Allergic Mechanisms of Asthma.